What question did this study set out to answer?

This research aims to enhance hematopoietic stem cell mobilization for transplantation using novel inhibitors.

June 12, 2026Open Access

Revolutionising hematopoietic stem cell mobilisation

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial explores enhanced mobilization of hematopoietic stem cells for blood malignancies, indicating improved safety and outcomes.

This research aims to enhance hematopoietic stem cell mobilization for transplantation using novel inhibitors.
Combination of CXCR4 and VLA-4 inhibitors used for HSC mobilisation.
Focus on improving efficiency, safety, and overall treatment outcomes in blood therapies.
Increased mobilization efficiency of HSCs from bone marrow to peripheral blood observed.
Enhanced safety profile and improved outcomes compared to traditional mobilisation regimens.

DiPersio et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial explores enhanced mobilization of hematopoietic stem cells for blood malignancies, indicating improved safety and outcomes.